These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease. Marei HE; Khan MUA; Hasan A Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028 [TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Grskovic M; Javaherian A; Strulovici B; Daley GQ Nat Rev Drug Discov; 2011 Nov; 10(12):915-29. PubMed ID: 22076509 [TBL] [Abstract][Full Text] [Related]
9. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Okano H; Morimoto S Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619 [TBL] [Abstract][Full Text] [Related]
10. Modeling human neurological disorders with induced pluripotent stem cells. Imaizumi Y; Okano H J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589 [TBL] [Abstract][Full Text] [Related]
11. Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines. Fujimori K; Tezuka T; Ishiura H; Mitsui J; Doi K; Yoshimura J; Tada H; Matsumoto T; Isoda M; Hashimoto R; Hattori N; Takahashi T; Morishita S; Tsuji S; Akamatsu W; Okano H Mol Brain; 2016 Oct; 9(1):88. PubMed ID: 27716287 [TBL] [Abstract][Full Text] [Related]
12. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases. Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228 [TBL] [Abstract][Full Text] [Related]
13. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery. Costamagna G; Andreoli L; Corti S; Faravelli I Cells; 2019 Nov; 8(11):. PubMed ID: 31739555 [TBL] [Abstract][Full Text] [Related]
14. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery. Corti S; Faravelli I; Cardano M; Conti L Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144 [TBL] [Abstract][Full Text] [Related]
15. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine. Silva MC; Haggarty SJ Ann N Y Acad Sci; 2020 Jul; 1471(1):18-56. PubMed ID: 30875083 [TBL] [Abstract][Full Text] [Related]
16. Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells. Xu XH; Zhong Z Acta Pharmacol Sin; 2013 Jun; 34(6):755-64. PubMed ID: 23685955 [TBL] [Abstract][Full Text] [Related]
17. Using stem cell-derived neurons in drug screening for neurological diseases. Little D; Ketteler R; Gissen P; Devine MJ Neurobiol Aging; 2019 Jun; 78():130-141. PubMed ID: 30925301 [TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells. Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255 [TBL] [Abstract][Full Text] [Related]
20. Accelerating progress in induced pluripotent stem cell research for neurological diseases. Ito D; Okano H; Suzuki N Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]